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Abstract 16 
Dietary restriction (DR) extends lifespan and healthspan in many species, but 17 
precisely how it elicits its beneficial effects is unclear. We investigated the impact of 18 
DR on mitochondrial function within liver and skeletal muscle of female ILSXISS 19 
mice that exhibit strain-specific variation in lifespan under 40% DR. Strains TejJ89 20 
(lifespan increased under DR), TejJ48 (lifespan unaffected by DR) and TejJ114 21 
(lifespan decreased under DR) were studied following 10 months of 40% DR (13 22 
months of age). Oxygen consumption rates (OCR) within isolated liver mitochondria 23 
were unaffected by DR in TejJ89 and TejJ48, but decreased by DR in TejJ114. DR 24 
had no effect on hepatic protein levels of PGC-1a, TFAM, and OXPHOS complexes 25 
I-V. Mitonuclear protein imbalance (nDNA:mtDNA ratio) was unaffected by DR, but 26 
HSP90 protein levels were reduced in TejJ114 under DR. Surprisingly hepatic 27 
mitochondrial hydrogen peroxide (H2O2) production was elevated by DR in TejJ89, 28 
with total superoxide dismutase activity and protein carbonyls increased by DR in 29 
both TejJ89 and TejJ114. In skeletal muscle, DR had no effect on mitochondrial 30 
OCR, OXPHOS complexes or mitonuclear protein imbalance, but H2O2 production 31 
was decreased in TejJ114 and nuclear PGC-1a increased in TejJ89 under DR. Our 32 
findings indicate that hepatic mitochondrial dysfunction associates with reduced 33 
lifespan of TejJ114 mice under 40% DR, but similar dysfunction is not seen in 34 
skeletal muscle mitochondria. We highlight tissue-specific differences in the 35 
mitochondrial response in ILSXISS mice to DR, and underline the importance and 36 
challenges of exploiting genetic heterogeneity to help understand mechanisms of 37 
ageing. 38 
 39 
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1.1 Introduction 42 
Dietary restriction (DR), in its most general sense; defined here as reductions 43 
in energy intake, reductions in specific macro or micronutrients or as intermittent 44 
fasting, is the most extensively applied experimental intervention employed to 45 
manipulate ageing and longevity [1], [2]. Since the first study demonstrating that DR 46 
extended the reproductive period and lifespan of female rats almost one century ago 47 
[3], an extensive body of research has studied the effects of DR in a wide number of 48 
organisms (reviewed in [1], [2], [4]–[6]). In addition to its effects on lifespan, DR also 49 
attenuates and/or postpones a broad-spectrum of age-associated pathologies, 50 
including obesity, insulin resistance, cognitive decline, immune dysfunction, stem cell 51 
ageing, sarcopaenia and cataracts [1], [2], [4], [5]. DR in rodents confers protection 52 
against a number of spontaneous and experimentally-induced cancers [6], and 53 
delays several age-associated pathologies, including metabolic and cardiovascular 54 
disease, cancer and brain atrophy in non-human primates [7]–[9]. Similarly, DR 55 
elicits numerous beneficial metabolic effects in humans including weight loss, lower 56 
visceral and intramuscular adiposity, insulin sensitivity and lowers several risk factors 57 
linked to cancer and cardiovascular disease [10], [11]. 58 
However, contrary to the belief that the effect of DR on longevity is universal, 59 
several studies have reported a lack of, or even a detrimental effect of, DR on 60 
lifespan [9], [12]–[16] (reviewed in [17]). In Rhesus macaques (Macaca mulatta), DR 61 
extended lifespan in a study conducted by the National Primate Research Center at 62 
the University of Wisconsin [7], but did not extend lifespan in a study undertaken by 63 
the National Institute of Health [9]. The precise reasons for the differing outcomes 64 
between these studies appears complex but may reflect inter-study differences in 65 
diet, animal husbandry and geographical origin [1], [7], [18]. In addition, a potentially 66 
critical factor that may help explain the unresponsiveness of particular organisms to 67 
DR-induced longevity is genetic background [1], [7], [18], [19]. For example, the 68 
effect of DR on survival in DBA/2 mice has been a source of debate for many years, 69 
with DR reported to extend [20], [21], have no effect [22], or shorten lifespan [14]. 70 
However, a recent study examining lifespan in male and female DBA/2 and C57BL/6 71 
mice under 20% and 40% DR revealed that DBA/2 mice are indeed responsive to 72 
DR, although the impact of sex, strain and the magnitude of DR on survival outcome 73 
appears important [23]. In two independent studies undertaken by the Universities of 74 
Texas [24] and Colorado [15], survival was determined in multiple strains of 75 
heterogeneous ILSXISS recombinant inbred mice maintained on 40% DR, with 76 
distinct strain-specific effects on survival observed following 40% DR. The first study 77 
[24] reported that across 39 female and 41 male strains studied, only 21% of female 78 
strains showed life extension under DR, and only 5% of male strains. Surprisingly, a 79 
greater number of strains (27% and 26% for females and males respectively) 80 
showed reduced lifespan under DR. The latter study [15], which assayed 42 female 81 
ILSXISS strains, similarly reported a significant strain-specific response to DR, with 82 
only 21% of strains showing life extension and 19% showing life shortening effects of 83 
DR.  84 
Despite DR being the primary experimental  intervention used to study 85 
ageing, it is still unclear as to precisely how DR acts mechanistically to induce its 86 
effects, although a multitude of mechanisms have been proposed [4], [5], [25]–[27]. 87 
Mitochondrial dysfunction is a key hallmark of ageing and disease [28], with ageing 88 
associated with altered mitochondrial morphology, reduced mitochondrial oxidative 89 
capacity and ATP production, increased mitochondrial-derived reactive oxygen 90 
species (ROS) generation and greater oxidative damage [29]. Consequently, 91 
significant research effort has investigated whether DR can induce beneficial effects 92 
on the mitochondrial phenotype, such as maintaining mitochondrial function during 93 
ageing, reducing ROS production and attenuating oxidative damage. While it is 94 
generally assumed that DR reduces ROS production, a recent meta-analysis 95 
involving 157 rodent DR studies in which ROS levels (primarily hydrogen peroxide) 96 
were assayed, highlighted that 62% of studies actually reported no change in ROS 97 
levels relative to ad libitum (AL) fed controls [30]. Ambiguity also exists regarding the 98 
effect of DR on mitochondrial respiration in rodents, with DR reported to increase 99 
[31]–[34], decrease [35], or have no effect relative to AL controls [36]. Similarly, the 100 
impact of DR on various antioxidants and markers of oxidative damage appears 101 
fairly inconclusive, although as with all these parameters tissue-specific effects, the 102 
duration and intensity of DR, the sex and the age of the animals at the point of study 103 
may affect experimental outcomes [30]. The concept that DR induces mitochondrial 104 
biogenesis, that is the production of new mitochondrial proteins, has been proposed 105 
as a critical mechanism underlying the beneficial effects of DR [37], with DR reported 106 
to induce mitochondrial biogenesis in a number of tissues including liver [33]. 107 
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) is 108 
described as the master regulator of mitochondrial biogenesis [38]. DR slows age-109 
related declines in Pgc-1α expression in rat skeletal muscle and heart, and it is 110 
proposed that mitochondrial function adapts to DR through PGC1α regulation [33], 111 
[39], [40]. However, there is considerable debate in the literature as to how best to 112 
quantify biogenesis. Indeed, several studies suggest that DR may increase 113 
mitochondrial efficiency in order to maintain an ‘optimally efficient’ electron transport 114 
system, potentially driven by the nuclear localisation of PGC1-α [39], [41] without any 115 
increase in mitochondrial number per se [31], [34], [42]. Hancock et al [42] examined 116 
a range of tissues, including liver and skeletal muscle, in rats and suggested that 117 
rather than altering rate of protein synthesis in the mitochondria that DR affords 118 
protection to mitochondria through defending against DNA damage. Similarly, Lanza 119 
et al [34] reported that DR did not stimulate the synthesis of new mitochondrial 120 
proteins in mouse skeletal muscle, but rather minimised damage to existing cellular 121 
components, through decreased mitochondrial oxidant emission and upregulated 122 
antioxidant defences. Indeed, mitochondrial protein synthesis within liver, muscle 123 
and heart of mice was unaffected by DR, although cellular proliferation was 124 
decreased [43], with a recent proteomic approach reporting that mitochondrial 125 
biogenesis may actually be reduced within liver of DR mice [44]. Consequently, such 126 
findings question the concept that DR increases mitochondrial biogenesis, and 127 
further challenge the somewhat counterintuitive idea of expending energy on protein 128 
synthesis at a time of energy and/or nutrient restriction [34].  129 
Recently, the role of mitonuclear protein imbalance, that is a stoichiometric 130 
imbalance between OXPHOS subunits encoded by nuclear DNA (nDNA) and 131 
mitochondrial DNA (mtDNA) which activates the cytoprotective mitochondrial 132 
unfolded protein response (UPRmt), in longevity control has gained significant 133 
coverage (see[45]–[48]). Both rapamycin and resveratrol induced mitonuclear protein 134 
imbalance and UPRmt in mouse hepatocytes in vitro [45]. UPRmt induction in C. 135 
elegans also appeared necessary for longevity in developing worms exposed to high 136 
glucose, but shortened lifespan when induced in adulthood [49]. Longevity in BXD 137 
mice is associated with reduced mitochondrial translation as determined by reduced 138 
expression of mitochondrial protein 5 (Mrps-5); Mrps-5 expression in skeletal muscle 139 
decreases with age and this is attenuated by DR [45]. In addition, skeletal muscle 140 
from long-lived Surf1-/- mice display evidence of UPRmt [50]. However, whether 141 
mitonuclear imbalance and UPRmt are important in DR-induced longevity in mice 142 
remains to be elucidated.  143 
Given the ongoing quest to identify the mechanistic drivers of DR, it has been 144 
suggested that employing a comparative-type approach which takes advantage of 145 
the variability in the DR response reported in certain rodent strains may help 146 
delineate the mechanisms underpinning DR [17], [19]. Indeed, several groups have 147 
already undertaken such approaches using DBA/2 mice [51]–[53], showing for 148 
example that this strain are hyperinsulinaemic and insulin resistant compared to 149 
C57BL/6 mice [54]. In the present study we investigated the potential linkage 150 
between DR-induced longevity and mitochondrial function within both liver and 151 
skeletal muscle by exploiting the highly variable effect of DR on lifespan in ILSXISS 152 
mice. To this end we compared females mice from three ILSXISS strains showing 153 
repeatable responses to DR across two independent studies [15], [24]; TejJ89 154 
(lifespan extended under DR relative to AL controls), TejJ48 (lifespan unaffected by 155 
DR), and TejJ114 (lifespan shortened under DR). We predicted that DR would 156 
positively impact on a number of parameters associated with mitochondrial function 157 
in strain TejJ89, that DR would have no impact on these parameters in strain TejJ48, 158 
and that DR would induce mitochondrial dysfunction in the negative responding 159 
TejJ114 (see Figure 1 for schematic outlining our original predictions).  160 
  161 
2. Materials and methods 162 
Animals  163 
ILSXISS recombinant inbred (RI) mouse strains are derived from a cross 164 
between inbred long sleep (ILS) and inbred short sleep (ISS) mice [55]. Mice from 165 
three strains; TejJ89, TejJ48 and TejJ114 were purchased from a commercial 166 
breeder (The Jackson Laboratory, Bar Harbour, Maine, URL: 167 
http://www.informatics.jax.org). The rationale for studying these particular strains 168 
was that in addition to repeatable effect of DR on lifespan across two independent 169 
studies [15], [24], no strain-specific differences in median lifespan were observed 170 
upon ad libitum (AL) feeding. Mice were maintained in groups of 4 post-weaning in 171 
shoebox cages (48cm×15cm×13cm), with AL access to water and standard chow 172 
(CRM(P), Research Diets Services, LBS Biotech, UK; Atwater Fuel Energy- protein 173 
22%, carbohydrate 69%, fat 9%) and maintained on a 12L/12D cycle (lights on 174 
0700–1900h) at 22±2°C. At 9 weeks of age, cages were assigned to either an AL or 175 
DR group, with no difference in body mass observed between treatment groups at 176 
this time (TejJ89 AL vs. DR t=0.056, p=0.583, TejJ48 AL vs. DR t=0.677, p=0.509, 177 
TejJ114 AL vs. DR t=0.289, p=0.777). Mice were introduced to DR in a graded 178 
fashion; at 10 weeks of age mice were exposed to 10% DR (90% of AL feeding), at 179 
11 weeks this was increased to 20% DR, and from 12 weeks of age until the 180 
termination of the experiment mice were exposed to 40% DR, relative to their 181 
appropriate strain-specific AL controls. Total food intake of AL mice from each strain 182 
was measured weekly (±0.01g) and food intake of the DR cohort calculated from the 183 
average AL intake per mouse over the preceding week [54]. DR mice were fed daily 184 
at 1800hrs and fed directly into the cage. Following 10 months of 40% DR 185 
(equivalent to 13 months of age), mice were fasted overnight and then culled the 186 
following morning by cervical dislocation. One lobe of liver, one gastrocnemius 187 
muscle and the heart were dissected out and immediately snap-frozen in liquid 188 
nitrogen and stored at -80°C until use. The remaining liver tissue and gastrocnemius 189 
muscle were subsequently used for the mitochondrial functional studies. A total of 4 190 
mice per day were culled, with the time between dissection, mitochondrial isolation 191 
and mitochondrial analysis kept as uniformed as possible, with the particular tissue 192 
(liver or skeletal muscle) processed and analysed alternated each day. All 193 
experiments were carried out under a licence from the UK Home Office (Project 194 
Licence 60/4504) and followed the “principles of laboratory animal care” (NIH 195 
Publication No. 86-23, revised 1985). 196 
Mitochondrial Respiration 197 
Isolation of Mouse Liver and Skeletal Muscle Mitochondria 198 
Liver mitochondria were isolated using previously published protocols [56], 199 
[57]. Briefly the liver was weighed and washed in MSHE+BSA buffer (210 mM 200 
mannitol, 70 mM sucrose, 5 mM HEPES, 1 mM EGTA and 0.5% (w/v) fatty acid free 201 
bovine serum albumin (pH 7.2)). The liver was rapidly minced with scissors in 10 202 
volumes of MSHE+BSA buffer before homogenisation (2-3 strokes) using a glass-203 
glass homogeniser (Fisher Scientific, Loughborough, UK). As with the liver, 204 
gastrocnemius muscle was harvested, weighed, washed and then minced in ice-cold 205 
isolation buffer (100 mM sucrose, 100mM KCL, 50mM Tris HCl, 1mM KH2PO4, 206 
0.1mM EGTA, 0.2% BSA (pH 7.4)), as set out in protocols previously described [58]. 207 
The muscle was subsequently rinsed three times in 1ml of fresh isolation buffer, and 208 
then 1ml of 2% Proteinase Type XXIV (Sigma Aldrich, Dorset, UK) was added and 209 
the sample vortexed for 1 min-1 at room temperature, followed by 1 min-1 incubation 210 
on ice. Samples were subsequently added to a glass homogeniser and 4ml of 211 
isolation buffer added before homogenisation (10 strokes). Using differential 212 
centrifugation for both liver [56] and muscle [58] a mitochondrial pellet was isolated 213 
and subsequently re-suspended (liver; MSHE buffer with no BSA, skeletal muscle; 214 
suspension buffer (225mM Mannitol, 75mM sucrose, 10mM Tris, 0.1mM EDTA (pH 215 
7.4)). Total liver and skeletal muscle mitochondrial protein (mg/ml) were determined 216 
using the Bradford assay (Sigma Aldrich, Dorset, UK). 217 
XF Assay – Plate Preparation 218 
Isolated mitochondria were diluted 10X in mitochondrial assay solution (MAS; 219 
70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1.0 220 
mM EGTA and 0.2% (w/v) fatty acid-free BSA, pH 7.2) containing substrate (10 mM 221 
pyruvate, 2 mM malate), and subsequently diluted to produce a 10µg mitochondrial 222 
suspension. Mitochondria were added to wells of a Seahorse XF assay plate (Agilent 223 
Technologies, CA, USA) at a concentration of 10µg per well. The plate was 224 
centrifuged at 2000g for 20 minutes at 4°C. A XF cartridge (Agilent Technologies) 225 
was then prepared as described by Brand et al. [56]. The plate was then transferred 226 
to a XF24 Analyser (Agilent Technologies) and the experiment initiated as previously 227 
described [57]. Basal Oxygen consumption rate (OCR) was measured in substrate 228 
(10 mM pyruvate, 2 µM malate). Following this OCR was sequentially recorded for 229 
state 3 (addition of ADP (4mM)), state 4 (addition of oligomycin (2.5 µg/ml)), state 3u 230 
(FCCP (4µM Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone)), and finally in 231 
the presence of Antimycin A and rotenone (40µM), inhibitors of Complex III and I 232 
respectively, to determine non-mitochondrial respiratory capacity [57]. Analysis was 233 
carried out using Seahorse XF software (www.seahorsebio.com). Respiratory control 234 
ratio, expressed as the ratio between state 3u (FCCP-induced maximal uncoupled-235 
stimulated respiration) and state 4o (respiration in the absence of ADP) did not differ 236 
by treatment within a strain or between strains for either liver or muscle mitochondria 237 
(Fig. S1A&B).  238 
Protein extraction 239 
Liver, skeletal muscle and heart tissue were suspended in 1ml of ice cold 240 
RIPA buffer (Radio Immuno Precipitation Assay buffer, 150 mM sodium chloride, 241 
1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS (sodium dodecyl 242 
sulphate), 50 mM Tris, pH 8.0) containing protease inhibitors (Halt™ Protease and 243 
Phosphatase Inhibitor Cocktail, Thermo Fisher Scientific, UK). The liver and heart 244 
were rapidly minced on ice with scissors and homogenised. A stainless steel bead 245 
(Catalogue # 69989, QIAGEN, Manchester, UK), was added to the eppendorf 246 
containing the skeletal muscle tissue and RIPA buffer, and then homogenised at 247 
maximum speed (30Hz) for 4 min-1 on the RETSCH MM 400 mixer mill (Catalogue# 248 
10573034, Fisher Scientific). Following homogenisation all lysates were incubated 249 
on ice for 40-60 min-1 before being centrifuged at 16,000 x g for 10 min-1 at 4°C, and 250 
total protein levels subsequently determined using the BCA protein assay (G 251 
Biosciences, MO, USA). Nuclear and cytoplasmic fractionation of liver and skeletal 252 
muscle was undertaken using the ReadyPrep™ Protein Extraction 253 
(Cytoplasmic/Nuclear) Kit (Catalogue #163-2089, Bio-Rad, UK). Briefly, ~50 mg of 254 
tissue was homogenised together with 0.75ml of cold cytoplasmic protein extraction 255 
buffer containing protease inhibitors (Halt™ Protease and Phosphatase Inhibitor 256 
Cocktail,) using a chilled Wheaton Dounce tissue homogeniser (Catalogue #62400-257 
595, VWR, West Sussex, UK), with protein concentration of each fraction determined 258 
using the BCA protein assay.  259 
Western Blot Analysis 260 
Equal volumes of tissue protein extract (50μg) in Laemmli sample buffer were 261 
loaded onto 4-12% Bis-Tris pre-cast polyacrylamide gels (Life Technologies, 262 
Paisley, UK). Following this, proteins were transferred to polyvinylidene difluoride 263 
membranes (BioRad). Ponceau staining was used to ensure equal loading of 264 
protein and for normalisation purposes. Membranes were incubated in Tris-buffered 265 
saline Tween (1X TBST) containing 5% BSA for 1h-1. Blots were then washed in 266 
TBST (5×5min), incubated with primary antibody for 24h-1 (4°C), washed again 267 
(TBST) and incubated with secondary antibody for 1h-1 at room temperature. Blots 268 
were visualised using Clarity™ Western ECL Substrate (BioRad) and a 269 
ChemiDoc™XRS system (BioRad). Antibodies for peroxisome proliferator-activated 270 
receptor-gamma co-activator 1 alpha (PGC-1α) and the oxidative phosphorylation 271 
complex antibody (OXPHOS cocktail; CI subunit NDUFB8, CII-30kDa (SDH), CIII-272 
Core protein 2 (UQCRC2), CIV subunit I (MTCO1) and CV alpha subunit (ATP5A) 273 
were from Abcam, Cambridge, UK, mitochondrial transcription factor A (TFAM) and 274 
secondary (anti-rabbit) antibodies from Santa Cruz Biotechnology Inc. (Santa Cruz, 275 
CA, USA), and HSP60 and HSP90 from BD Biosciences (BD Biosciences, Oxford, 276 
UK. Mitonuclear protein imbalance (nDNA:mtDNA ratio) was determined by the 277 
ratio of nuclear encoded SDHB (Complex II) to mitochondrial-encoded MTCO1 278 
(Complex IV) as described previously [45].  279 
Mitochondrial ROS production 280 
Fresh respiratory medium (MAS; 70 mM sucrose, 220 mM mannitol, 10 mM 281 
KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1.0 mM EGTA and 0.2% (w/v) fatty acid-free 282 
BSA, pH 7.2) was supplemented with 1U/ml horseradish peroxidase and 10 uM 283 
Amplex® Red reagent (ThermoFisher Scientific, UK) as previously described [59]. 284 
90µl of this medium was then added to each well of a standard 96 well plate 285 
(Costar®, Sigma Aldrich, UK) and heated for two min-1 at 37°C. Fluorescence was 286 
then measured at 15 second intervals for 2-3 min using a spectrophotometer 287 
(Clariostar microplate reader, BMG Labtech) at excitation and emission wavelength 288 
of 563 and 587nm respectively. A sequential protocol was then run simultaneously 289 
for each sample in triplicate and completed within 15 min-1. First the baseline 290 
fluorescence was measured by adding 10ul of mitochondrial suspension, and then 291 
mitochondrial hydrogen peroxide production from all complexes was determined by 292 
adding a saturating concentration of succinate (10mM), and then rotenone added 293 
(0.5uM; an inhibitor of complex I). The fluorescence signal was calibrated using 176 294 
nM of hydrogen peroxide, and then hydrogen peroxide production was calculated 295 
following background correction.  296 
Oxidative damage and antioxidant levels 297 
Protein carbonyl (PC), total glutathione (GSH) and total superoxide dismutase 298 
(SOD) activity were measured in liver samples using commercially available kits and 299 
following the manufacturer’s protocols (Catalogue#10005020 Carbonyl assay kit, 300 
#706002 Total SOD activity assay kit, #703002 Glutathione assay kit, Cayman 301 
Chemical Company, Estonia). Hepatic 4-Hydroxynonenal (HNE)-protein adduct 302 
levels were determined using an anti-HNE-His mouse IgG protein binding plate 303 
(Catalogue#STA-838, Cell Biolabs Inc., CA, USA). All assays were read on a plate 304 
reader (BMG Labtech, UK).  305 
Statistical Analysis  306 
All statistical analyses were performed using R and figures were produced 307 
using GraphPad Prism (GraphPad Inc., La Jolla, CA, USA, version 5) software. Data 308 
were checked for normality using the Shapiro–Wilks test and a logarithmic 309 
transformation was undertaken if data not normally distributed. Data was analysed 310 
using linear modelling (LM) with treatment (AL or DR) and strain (TejJ89, TejJ48 and 311 
TejJ114) introduced as fixed factors. Following transformation, if the data was not 312 
normally distributed an appropriate non-parametric test was applied. Results are 313 
reported as mean±standard error of the mean (SEM), with p<0.05 regarded as 314 
statistically significant.  315 
  316 
3. Results 317 
Mitochondrial oxygen consumption rates (OCR) within isolated liver 318 
mitochondria under all conditions studied (Fig. 2A) were unaffected by 10 months of 319 
40% DR in strain TejJ89 relative to AL controls. A similar lack of a DR effect on 320 
hepatic respiratory capacities was observed in strain TejJ48 (Fig. 2B). In contrast, 321 
DR in strain TejJ114 (Fig. 2C) significantly reduced State 3 (t = 2.860, p = 0.006) and 322 
State 3u (t = 2.950, p=0.006) mitochondrial OCR relative to AL controls. While no 323 
differences in mitochondrial OCR were observed across ILSXISS strains under AL 324 
feeding (Fig. 2D), State 3 OCR in TejJ89 was significantly increased (t= 2.24, 325 
p=0.039) relative to the other two strains under DR (Fig. 2E). 326 
Mitochondrial hydrogen peroxide (H2O2) production within liver was increased 327 
significantly (t=3.555, p=0.002) by DR in strain TejJ89 relative to its appropriate 328 
control, but DR had no effect on H2O2 production in strains TejJ48 and TejJ114 (Fig. 329 
3A). While no difference between strains in H2O2 production was observed under AL 330 
feeding (Fig. 3B), strain TejJ89 had significantly higher ROS levels compared to 331 
TejJ48 and TejJ114 under DR, and TejJ48 had significantly higher ROS levels 332 
(t=2.339, p=0.039) compared to TejJ114 (Fig. 3C). Total hepatic SOD activity was 333 
increased by DR treatment in strains TejJ89 (t = 3.776, p=0.004) and TejJ114 (t = 334 
2.845, p = 0.010) relative to their respective AL controls (Fig. 4A), but no strain-335 
specific effect on SOD activity was observed under either AL or DR feeding (Fig. 336 
S2A & B). Liver total glutathione (Fig. 4B; Fig. S2C and D) and 4-HNE (Fig. 4C; Fig. 337 
S2E & F) were unaffected by either treatment or strain. However, hepatic protein 338 
carbonyl (PC) levels (Fig. 4D) were significantly increased in strains TejJ89 (t=2.420, 339 
p=0.037) and TejJ114 (t=2.440, p=0.040) under DR when compared to their 340 
respective AL controls. In addition, while PC levels were not different between 341 
strains under AL feeding (Fig. S2G), hepatic PC levels were significantly lower in 342 
TejJ48 compared to both TejJ89 (t=6.860, p<0.001) and TejJ114 (t=3.220, p=0.010) 343 
under DR (Fig. S2H).  344 
Total hepatic protein levels of PGC-1α (Fig. 5A), a key transcriptional co-345 
activator linked to mitochondrial metabolism and biogenesis, was unaltered by 346 
treatment or strain, with both nuclear (Fig. 5B) and cytoplasmic (Fig. 5C) PGC-1α 347 
levels likewise unaffected. Similarly, mitochondrial transcription factor A (TFAM), a 348 
key activator of mitochondrial transcription, was unaffected by DR or strain (Fig. 5D). 349 
We then examined various OXPHOS complexes within liver, but again observed no 350 
treatment effect or observed any differences between strains under AL or DR 351 
feeding (Figure S3A-C). Given the evidence of mitochondrial dysfunction in TejJ114, 352 
we then went on to investigate whether DR induced mitonuclear protein imbalance 353 
and UPRmt by firstly calculating the ratio of nuclear encoded SDHB to mitochondrially 354 
encoded MTCO1 as previously described [45]. We observed no effect of either 355 
treatment or strain on mitochondrial nuclear imbalance (Fig. 6A-C). No differences 356 
were observed between either treatment groups or strains in the mitochondrial 357 
chaperone HSP60 (Fig. 6D), but a significant reduction in hepatic HSP90 (Fig. 6E) 358 
was observed in strain TejJ114 under DR (t=2.267, p=0.045) relative to AL controls.  359 
In order to determine whether mitochondrial dysfunction in strain TejJ114 was 360 
specific to liver, we also examined a number of mitochondrial parameters in isolated 361 
skeletal muscle from these same mice. No treatment or strain-specific differences in 362 
mitochondrial OCR were observed (Fig. 7A-E). Skeletal muscle mitochondrial H2O2 363 
production significantly reduced under DR in strain TejJ114 (Mann Whitney p=0.009) 364 
(Fig. 9A) compared to AL controls, but unaffected by DR in the other two strains. No 365 
differences in mitochondrial H2O2 production was observed between strains under 366 
AL feeding (Fig. 9B), but was significantly reduced in TejJ114 under DR relative to 367 
TejJ89 (t=2.903, p=0.044) and TejJ48 (Mann Whitney p=0.009). Similar to liver, total 368 
and cytosolic PGC1α levels (Fig. 8A & B) were unaffected by DR in all strains, 369 
although nuclear PGC1α levels were increased in TejJ89 (t=3.174, p=0.034). Protein 370 
levels of various OXPHOS complexes and mitonuclear protein imbalance within 371 
skeletal muscle were unaffected by treatment and strain (Figure S3D-F; Fig. 10A), as 372 
was also the case in heart (Fig. S3G-I; Fig. 10B).   373 
4. Discussion 374 
The phenotypic plasticity of the mitochondria is crucial to allow energetic 375 
demands to be met and in order to sustain bioenergetic efficiency [42], [60]. 376 
Consequently impairments in this dynamic system can lead to profound health 377 
consequences, with mitochondrial dysfunction widely proposed as a hallmark of 378 
ageing [61], [62]. As discussed earlier, enhanced mitochondrial function has been 379 
put forward as a candidate mechanism underlying the beneficial effects of DR on 380 
lifespan and healthspan [63], [64]. Here we sought to investigate mitochondrial 381 
function in using a comparative approach in ILSXISS mice which are known to show 382 
significant strain-specific variation in lifespan under 40% DR [15], [24].  383 
Contrary to our initial predictions, 40% DR did not alter hepatic mitochondrial 384 
respiratory capacity in strain TejJ89, which is reported to show lifespan extension 385 
under DR. While several studies have reported that DR increases mitochondrial 386 
respiratory capacity in rodents [31]–[34], other studies have reported a DR-induced 387 
decrease [65], [35], [66], or no effect of DR on mitochondrial respiratory capacity 388 
[36], [67] relative to AL controls. The precise reasons for this ambiguity appears 389 
complex but the tissue studied, the preparation used (isolated mitochondria vs. 390 
permeabilised tissue vs. tissue homegenate), the duration, age of onset and level of 391 
DR imposed, and the sex, age and the genetic background of the animal may all be 392 
important [31], [64], [68], [69]. Strain TejJ48 under DR, as predicted, displayed 393 
essentially no mitochondrial phenotype relative to its AL control. However, in strain 394 
TejJ114, mitochondrial respiratory capacity associated with State 3 and State 3u 395 
(maximal uncoupled oxygen consumption rates) were significantly reduced under 396 
DR. Both ageing and many pathologies associated with ageing reduce mitochondrial 397 
respiratory capacities in a range of tissues [70], [71], and the apparent DR-induced 398 
hepatic mitochondrial dysfunction may offer new insights in to why DR truncates 399 
lifespan in this particular ILSXISS strain. To determine whether the hepatic 400 
mitochondrial dysfunction in TejJ114 was liver-specific, we determined mitochondrial 401 
respiratory capacity in isolated skeletal muscle mitochondria in these same ILSXISS 402 
mice under AL and DR feeding. Despite DR known to preserve mitochondrial 403 
function during ageing in certain mouse strains, such as C57BL/6 and male B6D2F1 404 
[31], [34], we saw no effect of DR on skeletal muscle mitochondrial respiratory 405 
capacity in any strain. In view of the well-defined role of PGC1α in modulating 406 
mitochondrial function, and given that that mitochondrial adaptations to DR may be 407 
driven through a PGC1α-induced transcriptional program [39], [41], [64], [72], we 408 
investigated protein levels of PGC1α within liver in each strain under AL and DR. In 409 
line with the absence of any effect of DR on mitochondrial respiratory capacity, we 410 
observed no increase in hepatic PGC1α (total, cytosolic, nuclear) or in mitochondrial 411 
transcription factor A (TFAM) protein levels of strain TejJ89 under DR. Similarly, 412 
PGC-1α and TFAM levels were unaffected by DR in strains TejJ48 or TejJ114. 413 
However, a tissue-specific response was observed with 40% DR significantly 414 
increasing nuclear PGC1α within skeletal muscle of strain TejJ89, in line with what 415 
has been reported in other studies (for review see[64]).  416 
We then employed an immunoblot approach to examine respiratory chain 417 
complexes I, II, III, IV and V, and we again observed no treatment effect in any 418 
strains for liver, skeletal muscle or in heart. Indeed, it has been reported that DR-419 
induced attenuation of ageing-associated declines in mitochondrial function within 420 
skeletal muscle appears to be independent of any effect on mitochondrial respiratory 421 
chain protein levels [34] However, this approach enabled us to examine mitonuclear 422 
protein imbalance; that is the ratio of nuclear encoded SDHB to mitochondrially 423 
encoded MTCO1. An increase in this ratio is associated with an induction in the 424 
cytoprotective mitochondrial unfolded protein response (UPRmt), a recently proposed 425 
conserved lifespan determinant [45]. We found no evidence that DR increased 426 
mitonuclear protein imbalance within the liver, skeletal muscle or heart of ILSXISS 427 
mice under DR feeding. The UPRmt invokes a transcriptional program in response to 428 
a number of processes, including mitochondrial dysfunction, resulting in the induction 429 
of various chaperones and proteases that help facilitate mitochondrial proteostasis 430 
[73]. We therefore, then examined the molecular chaperones HSP60 and HSP90, 431 
and similarly showed a lack of any treatment effect across our strains, except for a 432 
significant reduction in HSP90 levels within liver of TejJ114 mice under DR. HSP90 433 
engages with a large number of ‘client’ proteins through co-chaperones, plays a 434 
major role in signal transduction, protects the 20S proteasome against oxidative 435 
inactivation and may actively regulate mitochondrial metabolism [74]–[76]. Whilst it is 436 
difficult to disentangle cause and effect here, our data indicates that in strain TejJ114 437 
40% DR leads to hepatic mitochondrial dysfunction and that this is correlated with 438 
reduced HSP90 levels. 439 
It is evident that both ageing and several disease states are associated with 440 
greater ROS-induced oxidative damage, but it is equivocal as to whether ROS-441 
induced oxidative damage is the mechanism underpinning ageing and disease [30], 442 
[77], [78]. A large number of studies have investigated whether DR can reduce ROS, 443 
induce various antioxidants and attenuated oxidative damage in model organisms. In 444 
an excellent recent meta-analysis, the Van Remmen laboratory [30] examined 445 
several hundred studies that have investigated the effect of DR in rodents on ROS 446 
production, various antioxidants and on oxidative damage. Their approach found that 447 
DR had remarkably little impact on ROS production or antioxidant activity overall, but 448 
53% of studies reported that DR reduced oxidative damage. Perhaps surprisingly we 449 
found that DR in strain TejJ89, which shows lifespan extension under 40% DR, had 450 
significantly higher hepatic mitochondrial H2O2 production, alongside greater hepatic 451 
total SOD activity and higher protein carbonyl levels relative to its appropriate AL 452 
control. In addition, TejJ89 had significantly higher hepatic mitochondrial H2O2 453 
production relative to the other two strains under DR feeding. Strain TejJ114 had 454 
increased hepatic total SOD activity and protein carbonyl levels relative to its AL 455 
controls, but mitochondrial ROS levels were not significantly altered. Similarly, the 456 
hepatic protein carbonyl levels in line TejJ114 under DR could not be explained by 457 
differences in hepatic NADPH oxidase levels (Fig. S4). The mitochondrial ROS 458 
profile in skeletal muscle was similar in skeletal muscle but H2O2 production was 459 
significantly reduced by DR in TejJ114 compared to its appropriate control and when 460 
compared to the other two strains under DR. Consequently, our findings further 461 
question the precise role of ROS-induced oxidative damage being the mechanism 462 
underpinning ageing. We can speculate that the increased ROS under DR in strain 463 
TejJ89 elicited a beneficial mitohormesis-like effect [79] resulting in DR-induced 464 
longevity, although this remains to be determined and does not appear to involve the 465 
UPRmt. As a small aside, it is particularly sobering to note that in the comprehensive 466 
meta-analysis on DR and oxidative stress in rodents undertaken by Walsh et al. [30], 467 
96% of all observations were made in male rodents, with the remaining 4% 468 
undertaken using females alone or mixed sex populations.  469 
In conclusion, our findings do not completely support our initial predictions (Fig. 470 
1), in which we forecast a clear continuum from the stimulatory and beneficial effects 471 
of DR on the mitochondrial phenotype in positive responding strain TejJ89 through to 472 
predicted mitochondrial dysfunction in strain TejJ114 under DR. In the positive 473 
responding strain TejJ89 we saw no evidence of a DR-induced increase in 474 
mitochondrial respiratory capacity in liver and muscle mitochondria or in PGC-1α 475 
levels within liver, although nuclear PGC-1α levels were induced in muscle. 476 
Paradoxically, TejJ89 had increased hepatic mitochondrial ROS production, greater 477 
SOD activity and higher hepatic protein carbonyl levels under DR, further highlighting 478 
the complexity between mitochondrial respiratory capacity, mitochondrial ROS and 479 
oxidative damage [80]. While strain TejJ114 under DR did show evidence of 480 
mitochondrial dysfunction within liver relative to AL controls, this effect was tissue-481 
specific as was not observed in skeletal muscle. What is clear is that it will now be 482 
important to investigate whether the liver-specific mitochondrial dysfunction observed 483 
in strain TejJ114 under 40% DR is evident under less restrictive feedings conditions, 484 
i.e. 10-30% DR, as for all these strains we do not currently know where exactly the 485 
optimal longevity ‘sweet-spot’ for these lines under DR sits. Our data also raises the 486 
possibility that DR-induced longevity in ILSXISS mice does not appear to involve 487 
mitonuclear imbalance and UPRmt, which also appears to be the case in worm DR 488 
(eat-2) mutants [81]. What is also clear is that almost all we know about the potential 489 
mechanisms underlying DR in rodents is based almost exclusively on C57BL/6 mice 490 
[19]. Consequently, there is a need for more studies using mouse strains in addition 491 
to C57BL/6 mice, e.g. ILSXISS, DBA/2, UM-HET3, as these models may help 492 
provide new insights in to ageing mechanisms that are public, i.e. shared, across all 493 
mouse strains rather than mechanisms that are private, i.e. specific to C57BL/6 494 
mice.  495 
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Figure legends 504 
Figure 1: Schematic showing the predicted mitochondrial functional response to 10 505 
months of 40% dietary restriction (DR) in three strains of female ILSXISS mice that 506 
show a differential response of DR on longevity (TejJ89 lifespan extension; TejJ48 507 
no change in lifespan; TejJ114 lifespan shortening).   508 
Figure 2: Mitochondrial respiration (Oxygen consumption rate, OCR) was unaltered 509 
by 10 months of 40% DR in isolated liver mitochondria from strains TejJ89 (A) and 510 
TejJ48 (B). In strain TejJ114 (C), a significant treatment effect was observed with 511 
State 3 and State 3u OCR significantly reduced under DR relative to AL mice. No 512 
strain differences on mitochondrial functional was observed in AL mice (D). (E) State 513 
3 respiratory capacity was significantly increased in strain TejJ89 under DR when 514 
compared with the other strains under DR. Values are expressed as mean ± SEM, 515 
with n = 8 per group. * denotes p<0.05. 516 
Figure 3: Hydrogen peroxide (H2O2) production within isolated liver mitochondria, 517 
expressed as fold change relative to respective AL controls. (A) H2O2 production was 518 
increased by DR only in strain TejJ89. H2O2 production was unaltered between 519 
strains under AL feeding (B), but under DR H2O2 production was elevated in strain 520 
TejJ89 compared to both TejJ48 and TejJ114, and strain TejJ48 produced more 521 
H2O2 than TejJ114. Values are expressed as mean ± SEM, with n = 6 per group. ** 522 
p<0.001, * p<0.05. 523 
Figure 4: Hepatic antioxidant defence and oxidative damage markers. (A) Total 524 
SOD activity was significantly increased by DR in strains TejJ89 and TejJ114 relative 525 
to their respective AL controls. (B) Total glutathione (GSH) and (C) 4-526 
Hydroxynonenal (HNE) levels were unaffected by treatment or strain. (D) Protein 527 
carbonyl (PC) levels were significantly increased by DR in strains TejJ89 and 528 
TejJ114 relative to AL controls. Values are expressed as mean ± SEM, where n= 6 529 
per group. ** p<0.001, * p<0.05. 530 
Figure 5: Total (A), nuclear (B), and cytosolic (C) hepatic PGC-1α protein levels. No 531 
treatment or strain differences in hepatic PGC-1α protein levels were observed (D) 532 
DR or strain similarly had no effect on hepatic TFAM levels. Values are expressed as 533 
arbitrary units (AU) relative to total protein (determined by Ponceau staining). All 534 
values are expressed as means ± SEM, where n = 6 per group.  535 
Figure 6: Hepatic mitonuclear protein imbalance, expressed as the ratio between the 536 
nuclear DNA (SDHB) relative to mitochondrial DNA (MTCO1). (A-C) Mitochondrial 537 
protein imbalance was unaffected by treatment or strain. No treatment or strain 538 
effects were detected in HSP60 levels, however hepatic HSP90 was significantly 539 
reduced by DR in strain TejJ114 compared to its AL counterpart. No differences in 540 
HSP90 levels were observed between strains within the AL or DR treatment groups. 541 
Values are expressed as arbitrary units (AU) relative to total protein (determined by 542 
Ponceau staining).  All values are expressed as means ± SEM, where n = 6 per 543 
group. * p< 0.05 544 
Figure 7: Mitochondrial respiration (Oxygen consumption rate, OCR) in isolated 545 
skeletal muscle mitochondria was unaltered by 10 months of 40% DR in all strains (A 546 
–C). Similarly no differences were observed between strains within the AL (D) or DR 547 
groups (E). Values are expressed as mean ± SEM, with n = 8 per group 548 
Figure 8: Total (A), nuclear (B), and cytosolic (C) PGC-1α protein levels in skeletal 549 
muscle. No differences in PGC-1α protein levels were observed by treatment in total 550 
(A) or cytosolic (C) skeletal muscle fractions. An increase in PGC-1α was observed 551 
in nuclear PGC-1α protein fraction with DR (B). Strain was not found to alter PGC-1α 552 
levels in total, nuclear or cytosolic proteins within either the AL or DR treatment 553 
group. Values are expressed as arbitrary units (AU) relative to total protein 554 
(determined by Ponceau staining). All values are expressed as means ± SEM, where 555 
n = 6 per group. * p< 0.05 556 
Figure 9: Skeletal muscle mitochondrial hydrogen peroxide (H2O2) production, 557 
expressed as fold change relative to respective AL controls. (A) H2O2 production was 558 
significantly decreased by DR in strain TejJ114. H2O2 production was unaltered 559 
between strains under AL feeding (B), but under DR feeding H2O2 production was 560 
reduced in strain TejJ114 relative to the other two strains. Values are expressed as 561 
mean ± SEM, with n = 6 per group. ** p<0.001, * p<0.05. 562 
Figure 10: Mitonuclear protein imbalance in gastrocnemius (A) and heart (B), 563 
expressed as the ratio between the nuclear DNA (SDHB) relative to mitochondrial 564 
DNA (MTCO1). No treatment or strains effects were detected. Values are expressed 565 
as arbitrary units (AU) relative to total protein (determined by Ponceau staining). All 566 
values are expressed as means ± SEM, where n = 6 per group.   567 
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